Pdb69 - Cost-Effectiveness Analysis of Adding Pioglitazone to Insulin Regimen in Type2 Diabetes in Iran

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.774
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Cost-Effectiveness of Pioglitazone in Type 2 Diabetes Patients With a History of Macrovascular Disease: A German Perspective

Cost Effectiveness and Resource Allocation
Health Policy
2009English

Pdb61 - Cost-Effectiveness Analysis of Human or Analogue Basal Insulin-Supported Oral Therapy in Type 2 Diabetes in Hungary

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Clinical and Cost-Effectiveness of Continuous Subcutaneous Insulin Infusion for Diabetes

Health Technology Assessment
MedicineHealth Policy
2004English

Pdb64 - Short-Term Cost-Effectiveness of Switching to Insulin Degludec in Japanese Patients With Type 2 Diabetes

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Cost-Effectiveness of Dapagliflozin as Add-On to Insulin for the Treatment of Type 2 Diabetes in the Netherlands

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Pioglitazone and Cardiovascular Outcomes in Patients With Insulin Resistance, Pre-Diabetes and Type 2 Diabetes: A Systematic Review and Meta-Analysis

BMJ Open
Medicine
2017English

Cost-Effectiveness of Insulin Degludec Compared With Insulin Glargine for Patients With Type 2 Diabetes Mellitus Initiating Insulin Therapy in the United Kingdom

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Insulin for Type 2 Diabetes: Choosing a Second-Line Insulin Regimen

International Journal of Clinical Practice
Medicine
2008English

Cost-Effectiveness of Sensor-Augmented Insulin Pump Therapy vs Continuous Subcutaneous Insulin Infusion in Patients With Type 1 Diabetes in the Netherlands

ClinicoEconomics and Outcomes Research
Health PolicyEconomicsEconometricsFinance
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy